z-logo
open-access-imgOpen Access
New Therapeutic and Biomarker Discovery for Peripheral Diabetic Neuropathy: PARP Inhibitor, Nitrotyrosine, and Tumor Necrosis Factor-α
Author(s) -
Viktor R. Drel,
Sergey Lupachyk,
Hanna Shevalye,
Іgor Vareniuk,
Weizheng Xu,
Jie Zhang,
Nicholas A. Delamere,
Mohammad Shahidullah,
Barbara S. Slusher,
Irina G. Obrosova
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.95.5.9978
Subject(s) - parp inhibitor , biomarker , peripheral neuropathy , medicine , nitrotyrosine , tumor necrosis factor alpha , diabetic neuropathy , peripheral , poly adp ribose polymerase , cancer research , diabetes mellitus , biology , polymerase , endocrinology , dna , biochemistry , nitric oxide synthase , nitric oxide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom